The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

A panel of experts on Thursday agreed that the bivalent COVID-19 vaccines should be used as both initial and booster shots, ...

The US Food and Drug Administration's committee of independent vaccine experts gathered Thursday to discuss the future of ...

Bivalent is better. Simple is better,” one FDA committee member said about vaccines that tackle the original strains of COVID ...

The monovalent COVID vaccines should be phased out and all people should receive the updated bivalent COVID vaccines, the FDA ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted unanimously to recommend that the agency ...

The U.S. Food and Drug Administration’s key science advisory panel, the Vaccines and Related Biological Products Advisory ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

Currently, Pfizer's and Moderna's omicron shots are authorized as a booster, while the first two doses are still the old shots based on the original strain.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

A single booster seems to prevent death and hospitalization in most people, but protection from the current vaccines wanes within months. FDA experts say they need to know more from ...